Key facts
- This page summarizes Anthony Vuoto's Form 4 filing for IRADIMED CORP (IRMD).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 10 Dec 2024, 21:00.
Anthony Vuoto - 07 Dec 2024 Form 4 Insider Report for IRADIMED CORP (IRMD)
- Reporting relationship
- Director
- Issuer ticker
- IRMD
- Reported as of
- 07 Dec 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Dec 2024, 21:00:08 UTC
- Prior SEC filing
- 06 Nov 2024
- Next SEC filing
- 13 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Anthony Vuoto
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Anthony Vuoto filed Form 4 for IRADIMED CORP (IRMD) on 10 Dec 2024.
Change
- Previous filing in this sequence was filed on 06 Nov 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IRMD
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +1,751
- Change %
- +12%
- Price
- Shares after
- 15,985
- Date
- 07 Dec 2024
- Ownership
- Direct
- Footnotes
- F1
IRMD
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +1,196
- Change %
- +7.5%
- Price
- Shares after
- 17,181
- Date
- 07 Dec 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IRMD
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,751
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 07 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,751
- Exercise price
- Footnotes
- F1, F2
IRMD
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,196
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 1,197
- Date
- 07 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,196
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Restricted stock units convert into common stock on a one-for-one basis.
Footnote F2
On December 7, 2022, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
Footnote F3
On December 7, 2023, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.